Elderly patients with gynaecological cancer: is the management individualized?

The change in life expectancy affects the presentation and the prognosis of elderly patients with gynaecological cancer. The authors performed a literature review in order to clarify if there are any changes in the treatment of such patients, and if their management should be considered to be individualized, depending on their age and comorbidities.

Octagenitarians; Cancer; Female genital tract; Treatment options.

[1] Colorectal Cancer Collaborative Group: “Surgery for colorectal cancer in elderly patients: a systematic review”. Lancet, 2000, 356, 968.

[2] Ríos A., Rodríguez J.M., Galindo P.J., Canteras M., Parrilla P.: “Surgical treatment for multinodular goiters in geriatric patients”. Langenbecks Arch. Surg., 2005, 390, 236.

[3] “Life expectancy at birth and at age 65 by local areas in the United Kingdom” Office for National Statistics, 2012.

[4] Europe in Figures: Eurostat yearbook 2008, European Communities, 2008.

[5] General Lifestyle Survey 2010 (Table 5.2), ONS, 2012.

[6] http://www.cancerresearchuk.org/cancer-info/cancerstats/types/ ovary/incidence/uk-ovarian-cancer-incidence-statistics

[7] Louwman W., Janssen-Heijnen M., Houterman S., Voogd A., van der Sangen M., Nieuwenhuijzen G., et al.: “Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study”. Eur. J. Cancer, 2005, 41, 779.

[8] Bastiaannet E., Portielje J., van de Velde C., de Craen A., van der Velde S., Kuppen P., et al.: “Lack of survival gain for elderly women with breast cancer”. Oncologist, 2011, 16, 415.

[9] Pallis A., Fortpied C., Wedding U., Van Nes M., Penninckx B., Ring A., et al. (2010) EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 46: 1502–1513.

[10] Houterman S., Janssen-Heijnen M., Verheij C., Louwman W., Vreugdenhil G., van der Sangen M., et al.: “Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients”. Br. J. Cancer, 2004, 90, 2332.

[11] Feldman S., Sirovich B.E., Goodman A.: “Screening for cervical cancer: Rationale and recommendations”. UpToDate, 2013.

[12] Skaznik-Wikiel M.E., Sukumvanich P., Austin R.M., Zorn K.K., Krivak T..C, Edwards R.P., Olawaiye A.B.: “Heavy cervical cancer burden in elderly women: how can we improve the situation?” Acta Cytol., 2012, 56, 388.

[13] Wright JD, Gibb RK, Geevarghese S, Powell MA, Herzog TJ, Mutch DG, Grigsby PW, Gao F, Trinkaus KM, Rader JS. Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer. 2005 Jan 1;103(1):85-91.

[14] Cetina L., Garcia-Arias A., Candelaria M., Cantú D., Rivera L., Coronel J., et al.: “Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients”. World J. Surg. Oncol., 2009, 7, 19.

[15] Giannice R., Susini T., Ferrandina G., Poerio A., Margariti P.A., Carminati R., et al.: “Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients”. Cancer, 2001, 92, 2562.

[16] Lowery W.J., Gehrig P.A., Ko E., Secord A.A., Chino J., Havrilesky L.J.: “Surgical staging for endometrial cancer in the elderly - is there a role for lymphadenectomy?” Gynecol Oncol., 2012, 126, 12.

[17] Uyar D, Frasure HE, Markman M, von Gruenigen VE. Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer. Gynecol Oncol. 2005 Sep;98(3):403-8.

[18] Chéreau E., Ballester M., Selle F., Rouzier R., Daraï E.: “Ovarian cancer in the elderly: impact of surgery on morbidity and survival”. Eur. J. Surg. Oncol., 2011, 37, 537.

[19] Fotopoulou C., Savvatis K., Steinhagen-Thiessen E., Bahra M., Lichtenegger W., Sehouli J.: “Primary radical surgery in elderly patients with epithelial ovarian cancer: analysis of surgical outcome and long-term survival”. Int. J. Gynecol. Cancer, 2010, 20, 34.

[20] Petignat P., Fioretta G., Verkooijen H.M., Vlastos A.T., Rapiti E., Bouchardy C., Vlastos G.: “Poorer survival of elderly patients with ovarian cancer: a population-based study”. Surg. Oncol., 2004, 13, 181.

[21] Allemani C., Storm H., Voogd A., Holli K., Izarzugaza I., TorrellaRamos A., et al.: “Variation in ‘standard care’ for breast cancer across Europe: a EUROCARE-3 high resolution study”. Eur. J. Cancer, 2010, 46, 1528.

[22] Giordano S., Hortobagyi G., Kau S., Theriault R., Bondy M.: “Breast cancer treatment guidelines in older women”. J. Clin. Oncol., 2005, 23, 783.

[23] White J., Morrow M., Moughan J., Owen J., Pajak T., DesHarnais S., et al.: “Compliance with breast-conservation standards for patients with early-stage breast carcinoma”. Cancer, 2003, 97, 893.

[24] Bouchardy C., Rapiti E., Blagojevic S., Vlastos A., Vlastos G.: “Older female cancer patients: importance, causes, and consequences of undertreatment”. J. Clin. Oncol., 2007, 25, 1858.

[25] Schonberg M., Marcantonio E., Ngo L., Li D., Silliman R., McCarthy E.: “Causes of death and relative survival of older women after a breast cancer diagnosis”. J. Clin. Oncol., 2011, 29, 1570.

[26] Van de Water W., Markopoulos C., van de Velde C., Seynaeve C., Hasenburg A., Rea D., et al.: “Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer”. JAMA, 2012, 307, 590.

[27] Markopoulos C., van de Water W.: “Older patients with breast cancer: is there bias in the treatment they receive?” Ther. Adv. Med. Oncol., 2012, 4, 321.

[28] One Voice: Shaping our ageing society, Age Concern and Help the Aged, 2009.

[29] Fitzpatrick J.M., Graefen M., Payne H.A., Scotté F., Aapro M.S.: “A comment on the International Society of GeriatricOncology guidelines: evidence-based advice for the clinical setting”. Oncologist, 2012, 17, 31.